| |
| |
|
| Insider
Information: |
Harr Steve |
| Relationship: |
President & CEO, Direc... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
8,173,750 |
|
|
Indirect Shares
|
682,500 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,856,250 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Juno Therapeutics, Inc. |
JUNO |
CFO & Head, Corp. Deve... |
2018-03-05 |
0 |
|
0 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
President & CEO, Direc... |
2021-02-08 |
8,173,750 |
2021-02-08 |
682,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SANA |
Sana Biotechnology, Inc. |
President & CEO |
• • – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,031,250 |
8,173,750 |
0 |
- |
|
| SANA |
Sana Biotechnology, Inc. |
President & CEOOfficer |
• • – |
2021-02-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
682,500 |
|
- |
|
| SANA |
Sana Biotechnology, Inc. |
President & CEOOfficer |
• • – |
2021-02-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,142,500 |
|
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-03-05 |
4 |
D |
$87.00 |
$42,834,885 |
D/D |
(492,355) |
147,162 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-03-05 |
4 |
D |
$0.00 |
$4,350,870 |
D/D |
(147,162) |
0 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,544 |
639,517 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-02-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
162,790 |
627,973 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-02-07 |
4 |
D |
$85.49 |
$145,675 |
D/D |
(1,704) |
790,763 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
29,135 |
792,467 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-12-21 |
4 |
AS |
$44.74 |
$391,674 |
D/D |
(8,750) |
763,332 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-12-21 |
4 |
OE |
$8.72 |
$76,300 |
D/D |
8,750 |
772,082 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,893 |
763,332 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-07-03 |
4 |
AS |
$30.00 |
$262,500 |
D/D |
(8,750) |
727,439 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-07-03 |
4 |
OE |
$8.72 |
$76,300 |
D/D |
8,750 |
736,189 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-06-27 |
4 |
AS |
$30.00 |
$262,501 |
D/D |
(8,750) |
727,439 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-06-27 |
4 |
OE |
$8.72 |
$76,300 |
D/D |
8,750 |
736,189 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,439 |
727,439 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
CFO & Head, Corp. Development |
• – – |
2016-06-10 |
4 |
AS |
$42.89 |
$1,299,530 |
D/D |
(30,000) |
700,000 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
See Remarks |
• – – |
2016-03-04 |
4 |
AS |
$45.00 |
$225,000 |
D/D |
(5,000) |
730,000 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
See Remarks |
• – – |
2016-03-01 |
4 |
AS |
$35.06 |
$1,127,342 |
D/D |
(30,000) |
735,000 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
See Remarks |
• – – |
2015-12-10 |
4 |
AS |
$46.38 |
$1,625,074 |
D/D |
(35,000) |
765,000 |
0 |
- |
|
| JUNO |
Juno Therapeutics, Inc. |
See RemarksOfficer |
• – – |
2014-12-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
800,000 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
